SlideShare ist ein Scribd-Unternehmen logo
1 von 12
Accounting for all randomised
 cases: handling non-compliance
and missing data in surgical trials

  Health Technology Assessment international Bilbao
                       2012



 Temitope Adewuyi, Jonathan Cook , Graeme MacLennan
                      Health Services Research Unit
                         University of Aberdeen



     HSRU is funded by the Chief Scientist Office of the Scottish Government Health
            Directorates. The author accepts full responsibility for this talk.
Outline


• Background

• Methods

• Results

• Conclusions
Background

What is a surgical trial?




 Saints Cosmas and Damian performing a miraculous transplantation
                (Courtesy: The Wellcome Library)
Challenges in surgical trials

• What is a perfect trial?

• Non-compliance
  – Equipoise

  – Surgery unnecessary/impossible

• Missing data at follow-up

  – Decline further follow-up
  – Non-response
Why does it matter?



Analysis             Difference (95% CI)



Intention-to-treat   2.4% (-1.0, 6.1)


Per-protocol         4.3% (0.7, 8.2)
                                        Hollis BMJ 1999
Aim




To assess non-compliance and missing

 data in RCTs of surgical procedures
Methods

• Search strategy: surgical trials published in
  2010 in six general medical journals and 12
  surgical journals
• Inclusion criteria: primary reports of RCTs
  involving at least one surgical procedure and
  any type of comparator

• Assessment: two independent reviewers
Results: Search

• Titles and abstracts screened: 462

• Full text assessed: 131

• Included studies: 92

  – General medical journals: 17 (18%)

  – Surgical journals: 75 (82%)
Results: Included studies

Number of arms           Two            82 (89%)

                         Three            8 ( 9%)

                         Four             2 ( 2%)

Number of participants   Median (IQR)   111 (65, 202)

                         Range           15 - 2522
Results: Non-compliance
Yes                     49 (60%)

      Median (IQR): 1% (0, 5%); n=79

Analysis approach:

 As-randomised          59 (74%)

 Per-protocol           18 (23%)

 As-treated              3 ( 4%)
Results: Missing data

Yes                60 (71%)

      Median (IQR): 6% (0, 15%); n=83

Methods of handling missing data:

 Simple            53 (88%)

 Complex            5 ( 8%)

 Not reported       2 ( 3%)
Conclusion

• Non-compliance and missing data are
 common but typically low levels

• Inadequate methods of handling missing
 data and non-compliance are still used

• Reporting of non-compliance and missing
 data is sub-optimal

Weitere ähnliche Inhalte

Was ist angesagt?

overveiw of critical apprasial
overveiw of  critical apprasial overveiw of  critical apprasial
overveiw of critical apprasial Amna Khairy
 
The Mesothelioma Center's January Support Group: Are Clinical Trials Right Fo...
The Mesothelioma Center's January Support Group: Are Clinical Trials Right Fo...The Mesothelioma Center's January Support Group: Are Clinical Trials Right Fo...
The Mesothelioma Center's January Support Group: Are Clinical Trials Right Fo...The Mesothelioma Center at Asbestos.com
 
Ebm misconception myths facts
Ebm misconception myths factsEbm misconception myths facts
Ebm misconception myths factsAboubakr Elnashar
 
Introduction to research methodology
Introduction to research methodologyIntroduction to research methodology
Introduction to research methodologyAmna Khairy
 
Error Trapping and Error Avoidance in Histopathology
Error Trapping and Error Avoidance in HistopathologyError Trapping and Error Avoidance in Histopathology
Error Trapping and Error Avoidance in Histopathologydrshameera
 
Standardization of Thyroid Function Tests, 05 05 - 2017
Standardization of Thyroid Function Tests, 05   05 - 2017Standardization of Thyroid Function Tests, 05   05 - 2017
Standardization of Thyroid Function Tests, 05 05 - 2017Ola Elgaddar
 
Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)Luis Bravo(Marketing)
 
951023 Electronically Screening Discharge Summaries For Adverse Medical Events
951023 Electronically Screening Discharge Summaries For Adverse Medical Events951023 Electronically Screening Discharge Summaries For Adverse Medical Events
951023 Electronically Screening Discharge Summaries For Adverse Medical Eventsplokm1580
 
The Paperless partograph – The new user-friendly and simpler tool for monitor...
The Paperless partograph – The new user-friendly and simpler tool for monitor...The Paperless partograph – The new user-friendly and simpler tool for monitor...
The Paperless partograph – The new user-friendly and simpler tool for monitor...iosrjce
 
JOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONJOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONKAVIYA AP
 
Defining Errors and Error Reduction in Pathology Laboratory: Revisited
Defining Errors and Error Reduction in Pathology Laboratory: RevisitedDefining Errors and Error Reduction in Pathology Laboratory: Revisited
Defining Errors and Error Reduction in Pathology Laboratory: RevisitedDr Felipe Templo Jr
 
Effect of Emergency Department and ICU Occupancy on Admission Decisions and O...
Effect of Emergency Department and ICU Occupancy on Admission Decisions and O...Effect of Emergency Department and ICU Occupancy on Admission Decisions and O...
Effect of Emergency Department and ICU Occupancy on Admission Decisions and O...Ching-wen Lu
 
Meta analysis and spontaneous reporting
Meta analysis and spontaneous reportingMeta analysis and spontaneous reporting
Meta analysis and spontaneous reportinghamzakhan643
 
Overview Of Ich New E9
Overview Of Ich New E9Overview Of Ich New E9
Overview Of Ich New E9Jay1818mar
 
Journal club in pharmacology
Journal club in pharmacologyJournal club in pharmacology
Journal club in pharmacologyDr Ketan Asawalle
 
Alvarado Syst Rv
Alvarado Syst RvAlvarado Syst Rv
Alvarado Syst RvNHS
 
PA 2015 Telephone Triage A0 size
PA 2015 Telephone Triage A0 sizePA 2015 Telephone Triage A0 size
PA 2015 Telephone Triage A0 sizeHarry Misselbrook
 

Was ist angesagt? (20)

overveiw of critical apprasial
overveiw of  critical apprasial overveiw of  critical apprasial
overveiw of critical apprasial
 
The Mesothelioma Center's January Support Group: Are Clinical Trials Right Fo...
The Mesothelioma Center's January Support Group: Are Clinical Trials Right Fo...The Mesothelioma Center's January Support Group: Are Clinical Trials Right Fo...
The Mesothelioma Center's January Support Group: Are Clinical Trials Right Fo...
 
Ebm misconception myths facts
Ebm misconception myths factsEbm misconception myths facts
Ebm misconception myths facts
 
Introduction to research methodology
Introduction to research methodologyIntroduction to research methodology
Introduction to research methodology
 
Error Trapping and Error Avoidance in Histopathology
Error Trapping and Error Avoidance in HistopathologyError Trapping and Error Avoidance in Histopathology
Error Trapping and Error Avoidance in Histopathology
 
Standardization of Thyroid Function Tests, 05 05 - 2017
Standardization of Thyroid Function Tests, 05   05 - 2017Standardization of Thyroid Function Tests, 05   05 - 2017
Standardization of Thyroid Function Tests, 05 05 - 2017
 
Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)
 
951023 Electronically Screening Discharge Summaries For Adverse Medical Events
951023 Electronically Screening Discharge Summaries For Adverse Medical Events951023 Electronically Screening Discharge Summaries For Adverse Medical Events
951023 Electronically Screening Discharge Summaries For Adverse Medical Events
 
The Paperless partograph – The new user-friendly and simpler tool for monitor...
The Paperless partograph – The new user-friendly and simpler tool for monitor...The Paperless partograph – The new user-friendly and simpler tool for monitor...
The Paperless partograph – The new user-friendly and simpler tool for monitor...
 
JOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONJOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATION
 
Defining Errors and Error Reduction in Pathology Laboratory: Revisited
Defining Errors and Error Reduction in Pathology Laboratory: RevisitedDefining Errors and Error Reduction in Pathology Laboratory: Revisited
Defining Errors and Error Reduction in Pathology Laboratory: Revisited
 
Effect of Emergency Department and ICU Occupancy on Admission Decisions and O...
Effect of Emergency Department and ICU Occupancy on Admission Decisions and O...Effect of Emergency Department and ICU Occupancy on Admission Decisions and O...
Effect of Emergency Department and ICU Occupancy on Admission Decisions and O...
 
Meta analysis and spontaneous reporting
Meta analysis and spontaneous reportingMeta analysis and spontaneous reporting
Meta analysis and spontaneous reporting
 
Overview Of Ich New E9
Overview Of Ich New E9Overview Of Ich New E9
Overview Of Ich New E9
 
Journal club in pharmacology
Journal club in pharmacologyJournal club in pharmacology
Journal club in pharmacology
 
27.SAR 2014
27.SAR 201427.SAR 2014
27.SAR 2014
 
Alvarado Syst Rv
Alvarado Syst RvAlvarado Syst Rv
Alvarado Syst Rv
 
Pharmacogenomic presentation medication saftey 110417 final2
Pharmacogenomic presentation  medication saftey 110417 final2Pharmacogenomic presentation  medication saftey 110417 final2
Pharmacogenomic presentation medication saftey 110417 final2
 
Pci vs tlt 2
Pci vs tlt 2Pci vs tlt 2
Pci vs tlt 2
 
PA 2015 Telephone Triage A0 size
PA 2015 Telephone Triage A0 sizePA 2015 Telephone Triage A0 size
PA 2015 Telephone Triage A0 size
 

Andere mochten auch

Fractions 3
Fractions 3Fractions 3
Fractions 3busiskin
 
Statistical Methods to Handle Missing Data
Statistical Methods to Handle Missing DataStatistical Methods to Handle Missing Data
Statistical Methods to Handle Missing DataTianfan Song
 
Statistical Approaches to Missing Data
Statistical Approaches to Missing DataStatistical Approaches to Missing Data
Statistical Approaches to Missing DataDataCards
 
Imputation techniques for missing data in clinical trials
Imputation techniques for missing data in clinical trialsImputation techniques for missing data in clinical trials
Imputation techniques for missing data in clinical trialsNitin George
 

Andere mochten auch (6)

Fractions 3
Fractions 3Fractions 3
Fractions 3
 
Statistical Methods to Handle Missing Data
Statistical Methods to Handle Missing DataStatistical Methods to Handle Missing Data
Statistical Methods to Handle Missing Data
 
Statistical Approaches to Missing Data
Statistical Approaches to Missing DataStatistical Approaches to Missing Data
Statistical Approaches to Missing Data
 
Missing data handling
Missing data handlingMissing data handling
Missing data handling
 
Missing Data and Causes
Missing Data and CausesMissing Data and Causes
Missing Data and Causes
 
Imputation techniques for missing data in clinical trials
Imputation techniques for missing data in clinical trialsImputation techniques for missing data in clinical trials
Imputation techniques for missing data in clinical trials
 

Ähnlich wie Accounting for all randomised cases: handling non-compliance and missing data in surgical trials. Temitope Adewuyi.

Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...HMO Research Network
 
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...HMO Research Network
 
SHE, Quality, and Ethics in Medical Laboratories - PCLP
SHE, Quality, and Ethics in Medical Laboratories - PCLPSHE, Quality, and Ethics in Medical Laboratories - PCLP
SHE, Quality, and Ethics in Medical Laboratories - PCLPAlAcademia Tsr
 
Using real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questionsUsing real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questionsKarin Verspoor
 
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016evadew1
 
Technology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic AnalysesTechnology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic Analysesevadew1
 
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.pptadrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.pptYelsingReyes
 
Identifying and Managing Pre-Diabetes: A systematic review of screening and i...
Identifying and Managing Pre-Diabetes: A systematic review of screening and i...Identifying and Managing Pre-Diabetes: A systematic review of screening and i...
Identifying and Managing Pre-Diabetes: A systematic review of screening and i...UKFacultyPublicHealth
 
NSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptx
NSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptxNSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptx
NSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptxNoel Eldridge
 
Chase presentation
Chase presentationChase presentation
Chase presentationReza Sadeghi
 
Knowledge transfer research examples
Knowledge transfer research examplesKnowledge transfer research examples
Knowledge transfer research examplestaem
 
Dekker trog - big data for radiation oncology - 2017
Dekker   trog  - big data for radiation oncology - 2017Dekker   trog  - big data for radiation oncology - 2017
Dekker trog - big data for radiation oncology - 2017Andre Dekker
 
Cadth 2015 b3 rapid reviews oral presentation cadth_11_apr2015
Cadth 2015 b3 rapid reviews oral presentation cadth_11_apr2015Cadth 2015 b3 rapid reviews oral presentation cadth_11_apr2015
Cadth 2015 b3 rapid reviews oral presentation cadth_11_apr2015CADTH Symposium
 
SAPC 2013 - general practice clinical systems
SAPC 2013 - general practice clinical systemsSAPC 2013 - general practice clinical systems
SAPC 2013 - general practice clinical systemsEvangelos Kontopantelis
 
RSS 2009 - Investigating the impact of the QOF on quality of primary care
RSS 2009 - Investigating the impact of the QOF on quality of primary careRSS 2009 - Investigating the impact of the QOF on quality of primary care
RSS 2009 - Investigating the impact of the QOF on quality of primary careEvangelos Kontopantelis
 
Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)jkglick57
 
Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)jkglick57
 
Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)jkglick57
 

Ähnlich wie Accounting for all randomised cases: handling non-compliance and missing data in surgical trials. Temitope Adewuyi. (20)

Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
 
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
 
SHE, Quality, and Ethics in Medical Laboratories - PCLP
SHE, Quality, and Ethics in Medical Laboratories - PCLPSHE, Quality, and Ethics in Medical Laboratories - PCLP
SHE, Quality, and Ethics in Medical Laboratories - PCLP
 
Using real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questionsUsing real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questions
 
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
 
Technology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic AnalysesTechnology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic Analyses
 
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.pptadrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
 
Identifying and Managing Pre-Diabetes: A systematic review of screening and i...
Identifying and Managing Pre-Diabetes: A systematic review of screening and i...Identifying and Managing Pre-Diabetes: A systematic review of screening and i...
Identifying and Managing Pre-Diabetes: A systematic review of screening and i...
 
NSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptx
NSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptxNSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptx
NSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptx
 
quality control in pathology
quality control in pathologyquality control in pathology
quality control in pathology
 
Chase presentation
Chase presentationChase presentation
Chase presentation
 
Knowledge transfer research examples
Knowledge transfer research examplesKnowledge transfer research examples
Knowledge transfer research examples
 
Dekker trog - big data for radiation oncology - 2017
Dekker   trog  - big data for radiation oncology - 2017Dekker   trog  - big data for radiation oncology - 2017
Dekker trog - big data for radiation oncology - 2017
 
Cadth 2015 b3 rapid reviews oral presentation cadth_11_apr2015
Cadth 2015 b3 rapid reviews oral presentation cadth_11_apr2015Cadth 2015 b3 rapid reviews oral presentation cadth_11_apr2015
Cadth 2015 b3 rapid reviews oral presentation cadth_11_apr2015
 
SAPC 2013 - general practice clinical systems
SAPC 2013 - general practice clinical systemsSAPC 2013 - general practice clinical systems
SAPC 2013 - general practice clinical systems
 
RSS 2009 - Investigating the impact of the QOF on quality of primary care
RSS 2009 - Investigating the impact of the QOF on quality of primary careRSS 2009 - Investigating the impact of the QOF on quality of primary care
RSS 2009 - Investigating the impact of the QOF on quality of primary care
 
KPIs in Microbiology
KPIs in Microbiology KPIs in Microbiology
KPIs in Microbiology
 
Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)
 
Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)
 
Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)Neal lesh-1202742298252135-3 (5)
Neal lesh-1202742298252135-3 (5)
 

Mehr von HTAi Bilbao 2012

How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...HTAi Bilbao 2012
 
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...HTAi Bilbao 2012
 
Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...HTAi Bilbao 2012
 
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The use of ‘colloquial evidence’ in HTA:  the experience of NICE The use of ‘colloquial evidence’ in HTA:  the experience of NICE
The use of ‘colloquial evidence’ in HTA: the experience of NICE HTAi Bilbao 2012
 
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...HTAi Bilbao 2012
 
Challenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated careChallenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated careHTAi Bilbao 2012
 
Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...HTAi Bilbao 2012
 
Assessing the International Use
Assessing the International Use Assessing the International Use
Assessing the International Use HTAi Bilbao 2012
 
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...HTAi Bilbao 2012
 
On the outside looking in.
On the outside looking in. On the outside looking in.
On the outside looking in. HTAi Bilbao 2012
 
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...HTAi Bilbao 2012
 
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...HTAi Bilbao 2012
 
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects databaseThe eunethta planned and ongoing projects database
The eunethta planned and ongoing projects databaseHTAi Bilbao 2012
 
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' supportEvaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' supportHTAi Bilbao 2012
 
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...HTAi Bilbao 2012
 
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degenerationBevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degenerationHTAi Bilbao 2012
 
Azienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of UdineAzienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of UdineHTAi Bilbao 2012
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...HTAi Bilbao 2012
 
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...HTAi Bilbao 2012
 

Mehr von HTAi Bilbao 2012 (20)

How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...How Glaucoma Patients Assess Different Aspects of Their Treatment?  An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
 
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
 
Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...Health Technology Assessment (HTA) Report: Interventions to increase particip...
Health Technology Assessment (HTA) Report: Interventions to increase particip...
 
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The use of ‘colloquial evidence’ in HTA:  the experience of NICE The use of ‘colloquial evidence’ in HTA:  the experience of NICE
The use of ‘colloquial evidence’ in HTA: the experience of NICE
 
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ens...
 
Challenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated careChallenges in commissioning research on what works in integrated care
Challenges in commissioning research on what works in integrated care
 
Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...Building a portfolio of research findings for use by healthcare managers and ...
Building a portfolio of research findings for use by healthcare managers and ...
 
Assessing the International Use
Assessing the International Use Assessing the International Use
Assessing the International Use
 
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
 
On the outside looking in.
On the outside looking in. On the outside looking in.
On the outside looking in.
 
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
 
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...
 
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects databaseThe eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
 
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' supportEvaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
 
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...
 
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degenerationBevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
 
Azienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of UdineAzienda ospedaliero Universitaria of Udine
Azienda ospedaliero Universitaria of Udine
 
HTAi in hospitals
HTAi in hospitalsHTAi in hospitals
HTAi in hospitals
 
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...
 
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
 

Kürzlich hochgeladen

systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 

Kürzlich hochgeladen (20)

systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 

Accounting for all randomised cases: handling non-compliance and missing data in surgical trials. Temitope Adewuyi.

  • 1. Accounting for all randomised cases: handling non-compliance and missing data in surgical trials Health Technology Assessment international Bilbao 2012 Temitope Adewuyi, Jonathan Cook , Graeme MacLennan Health Services Research Unit University of Aberdeen HSRU is funded by the Chief Scientist Office of the Scottish Government Health Directorates. The author accepts full responsibility for this talk.
  • 2. Outline • Background • Methods • Results • Conclusions
  • 3. Background What is a surgical trial? Saints Cosmas and Damian performing a miraculous transplantation (Courtesy: The Wellcome Library)
  • 4. Challenges in surgical trials • What is a perfect trial? • Non-compliance – Equipoise – Surgery unnecessary/impossible • Missing data at follow-up – Decline further follow-up – Non-response
  • 5. Why does it matter? Analysis Difference (95% CI) Intention-to-treat 2.4% (-1.0, 6.1) Per-protocol 4.3% (0.7, 8.2) Hollis BMJ 1999
  • 6. Aim To assess non-compliance and missing data in RCTs of surgical procedures
  • 7. Methods • Search strategy: surgical trials published in 2010 in six general medical journals and 12 surgical journals • Inclusion criteria: primary reports of RCTs involving at least one surgical procedure and any type of comparator • Assessment: two independent reviewers
  • 8. Results: Search • Titles and abstracts screened: 462 • Full text assessed: 131 • Included studies: 92 – General medical journals: 17 (18%) – Surgical journals: 75 (82%)
  • 9. Results: Included studies Number of arms Two 82 (89%) Three 8 ( 9%) Four 2 ( 2%) Number of participants Median (IQR) 111 (65, 202) Range 15 - 2522
  • 10. Results: Non-compliance Yes 49 (60%) Median (IQR): 1% (0, 5%); n=79 Analysis approach: As-randomised 59 (74%) Per-protocol 18 (23%) As-treated 3 ( 4%)
  • 11. Results: Missing data Yes 60 (71%) Median (IQR): 6% (0, 15%); n=83 Methods of handling missing data: Simple 53 (88%) Complex 5 ( 8%) Not reported 2 ( 3%)
  • 12. Conclusion • Non-compliance and missing data are common but typically low levels • Inadequate methods of handling missing data and non-compliance are still used • Reporting of non-compliance and missing data is sub-optimal

Hinweis der Redaktion

  1. Good afternoon, I’m Temitope Adewuyi from the University of Aberdeen. the title of my project is “Accounting for all randomised cases: handling non-compliance and missing data in surgical trials”. I acknowledge my co-authors.
  2. I’ll start with the “Background”, then the “Methods”, “Results” and finally the “Conclusions.”
  3. A surgical trial is defined as one which involves interventions that physically change body tissues and organs through manual operation such as cutting, abrading, suturing or the use of lasers.
  4. In a perfect trial patients receive the allocated intervention and have complete follow-up data. In addition to the usual causes of non-compliance in all trials, surgical trials may be more prone to other reasons for patients receiving something other then the allocated intervention. Examples of these reasons are: Lack of surgical skill equipoise or differences in surgical learning curve Intra-op change in management because surgery was deemed unnecessary or impossible As blinding may be impractical, patients may have preference for an other procedures Missing data result when patients decline further follow up or there is non-response possibly due to resentful demoralisation from not getting the treatment option they hoped for. This is common when blinding is impractical.
  5. The table shows the results from a trial of medical vs surgical management of angina. In that trial, some medical patients deviated to surgery on the surgeon’s advice but on the operating table, some of them had inoperable arteries had to continue on tablets. The investigators did ITT and got a difference in mortality of 2.4% which was non-significant. If they had excluded patients who did not get the allocated treatment, the difference in mortality would be 4.3% and significant. The investigators used ITT so as to minimise bias that could result from self-selecting patients into ad hoc groups. Therefore, how one deals with non-compliance and missing data may affect trial results.
  6. Slide 8: Aim and Objectives The aim of this review was to assess non-compliance and missing data in RCTs of surgical procedures.
  7. We conducted a systematic review of methodology and systematically searched in MEDLINE for surgical RCTs published in 2010 in six general medical journals and 12 surgical journals Only primary reports of RCTs involving at least one surgical procedure were included. Two independent reviewers assessed abstracts and full texts.
  8. Of 462 titles and abstracts, 131 full texts were assessed and 92 were included. Seventeen and 75 of the included studies were from the GMJs and SJs respectively.
  9. There were 82 two arm, eight three arm and two four arm studies . The median number of participants per study was 111 with an IQR of 65, 202 and a range of 15 to 2522.
  10. In 81 studies, the occurrence of non-compliance was ascertainable while it was not in 11 studies. Of the 81 studies, 49 had non-compliance and in 2 of the 49, it was not quantifiable. The commonest reason for non-compliance were challenges related to surgical technique or contraindications to surgery. Patient’s preference for another procedure was also a common reason for non-compliance while there were a few instances of unavailability of surgical materials. The median non-compliance was 1% with an IQR of 0 to 5%. In the 11 studies in which the occurrence of non-compliance was not ascertainable, the method of analysis of the primary outcome was not ascertainable either. Therefore, of the remaining 81, 59 analysed as randomised, 18 per-protocol, 3 as treated and in one study, the method used was unclear.
  11. In 84 studies, the occurrence of missing data was ascertainable while it was not in 8 studies. Of the 84 studies, 60 had missing data and in 1 of the 60, it was not quantifiable. The commonest reason for missing data were loss to follow-up/non-response and missed visits. Patient’s preference for another procedure was also a common reason for non-compliance while there were a few instances of unavailability of surgical materials. The median missing data was 6% with an IQR of 0 to 15%. In the 8 studies in which the occurrence of missing data was not ascertainable, the method of handling missing data was not ascertainable either. Therefore, of 60 studies with missing data, 53 used simple methods such as complete-case analysis, simple imputations, log rank test, Cox regression and survival analysis; 5 used complex methods such as regression and multiple imputations and Mixed model effect and in 2 studies, the method was not reported.
  12. We concluded that non-compliance and missing data are common but typically low levels. Inadequate methods of handling missing data and non-compliance are still used as the vast majority of studies used simple methods of handling missing data despite widespread availability of more robust techniques. Reporting of non-compliance and missing data is sub-optimal as 12% and 9% of studies did not comment on the occurrence or otherwise of non-compliance and missing data respectively).